Coverage of hospitals, clinics, public health, and mental health developments and initiatives.
A drug some are calling the female Viagara is one step closer to market. Ophena, developed by Ann Arbor drug company QuatRX Pharmaceuticals Co., was designed to treat a post-menopausal condition that makes sexual activity difficult or painful. QuatRX recently reported good results from a late-stage study.
A tiny device developed by University of Michigan scientists has made the impossible possible - using the tiny nano-voltmeter, scientists have been able to measure the electric field inside a cell.
You may not know what a cytometer does, but here's what it means for one Michigan company: jobs, growth, expansion.
Multi-national pharmaceutical company AstroZeneca has licensed a database created by Ann Arbor start-up Compendia Bioscience, Inc., created for cancer profiling.
Minimally invasive procedure is safer for many patients. Not convinced? Why not check it out onlive... live!
Starting next year, the University of Michigan will invest nearly $42.9 million in the university health system's medical imaging project.
The University of Michigan's $2.5 billion "Michigan Difference Campaign" proves that UofM isn't one of the country's largest endowments for nothing.
Our Partners
